SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-052385
Filing Date
2020-04-28
Accepted
2020-04-28 16:06:29
Documents
12
Period of Report
2020-04-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2017836d1_8k.htm   iXBRL 8-K 30526
  Complete submission text file 0001104659-20-052385.txt   204777

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20200424.xsd EX-101.SCH 3174
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20200424_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20200424_pre.xml EX-101.PRE 22702
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2017836d1_8k_htm.xml XML 3609
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 20825005
SIC: 2834 Pharmaceutical Preparations